Randomized Controlled Trials Evaluating Artificial Intelligence in Cardiovascular Care: A Systematic Review.

ABSTRACT:

Background

Artificial intelligence (AI) has shown promise in transforming health care, particularly in cardiology. However, there is a lack of high-quality evidence demonstrating its impact on crucial clinical outcomes.

Objectives

The purpose of this study was to synthesize existing evidence from randomized controlled trials (RCTs) on the application of AI in cardiology, evaluating its impact on key clinical outcomes.

Methods

We conducted a systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, searching MEDLINE, Web of Science, and the Cochrane Library from inception to November 2024. We included RCTs evaluating machine learning models compared to traditional methods in cardiovascular care. Primary outcomes

SUBMITTER: Hadida Barzilai D 

PROVIDER: S-EPMC12506480 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature